SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950159-14-000100
Filing Date
2014-02-24
Accepted
2014-02-24 16:52:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. quakerbioii13da.htm SC 13D/A 73516
  Complete submission text file 0000950159-14-000100.txt   75109
Mailing Address 7 GREAT VALLEY PARKWAY SUITE 300 MALVERN PA 19355
Business Address 7 GREAT VALLEY PARKWAY SUITE 300 MALVERN PA 19355 610-232-0800
NUPATHE INC. (Subject) CIK: 0001375200 (see all company filings)

IRS No.: 202218246 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85616 | Film No.: 14637590
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A